| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.2 | 1e-06 |